Pharmaco Group is extending its production line with six new drugs, which belong both to already existent and new therapeutic groups. Reportedly, Domestic pharmaceutical company keeps on developing the list of modern and demanded generics, taking into consideration Kyrgyzstan market needs and strictly following the worked out program of import substitution.
Pharmaco has also started to develop new directions by adding two other therapeutic groups to its production line – antihistaminic drugs (Loratadin Pharmaco) and vitamins (Glycin and Folacin).
Evgenii Svinuhov, operations manager of Pharmaco Group, said: “We have started to produce six new medications: prescribed antibiotics Cefepime, Cyprofloxacine and Phozinopril, which has antihypertensive effect, and also drugs, that can be sold in drug store without doctor’s prescription – Loratadin, Glycin and Folacin. From now on, there are 25 medications in production line of Pharmaco Group, which are used in gastroenterology, dermatology, gynecology, urology, rheumatology, cardiology, and pediatrics.”
Alexandr Karpov, the general manager of Pharmaco Group, said: “The decision to extend range of drugs with antibiotics, medicines, that improves functions of cardiovascular system, drugs against allergies and vitamins, was made by taking into account the demand of Kyrgyz people. Nowadays, we observe the increase in the number of able-bodied citizens, who are susceptible to vascular heart diseases. We have introduced modern and highly effective antihypertensive medication, ACE inhibitor of the third generation – Phozinopril Pharmaco for them.”